<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ARQT
Arcutis Biotherapeutics
$
()


  • Short Report: Bears squeeze MicroStrategy as shares track bitcoin higher

    2/10/2024 - 11:26am
  • Arcutis Biotherapeutics files $300M mixed securities shelf

    1/31/2024 - 17:23pm
  • Arcutis announces JAAD published results from trial evaluating ZORYVE

    1/29/2024 - 08:12am
  • Arcutis Biotherapeutics announces launch of ZORYVE topical foam in U.S.

    1/22/2024 - 08:01am
  • Arcutis Biotherapeutics announces new individual patient response data

    1/15/2024 - 08:14am
  • Arcutis Biotherapeutics announces new subgroup analysis from STRATUM study

    1/15/2024 - 08:12am
  • Largest borrow rate increases among liquid names

    1/3/2024 - 08:45am
  • Mizuho upgrades Arcutis, doubles target on Zoryve momentum

    1/2/2024 - 16:19pm
  • Mizuho gets more bullish on Arcutis Biotherapeutics, upgrades shares

    1/2/2024 - 16:12pm
  • Arcutis Biotherapeutics announces FDA approval of NDA for ZORYVE topical foam

    12/15/2023 - 17:13pm
  • Arcutis Biotherapeutics announces U.S. FDA accepted sNDA for roflumilast cream

    11/29/2023 - 08:03am
  • Arcutis Biotherapeutics downgraded to Hold from Buy at JonesResearch

    11/7/2023 - 16:18pm
  • Arcutis Biotherapeutics price target lowered to $8 from $22 at Needham

    11/6/2023 - 08:02am
  • Arcutis Biotherapeutics reports Q3 EPS (73c), consensus (91c)

    11/3/2023 - 07:33am
  • Short Report: ChargePoint, Luminar short positions at highest levels in weeks

    10/29/2023 - 15:08pm
dynamic_feed Breaking News